oleanolic acid has been researched along with D-fructopyranose in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, T; Li, Y; Wang, J; Yamahara, J | 1 |
Dinda, AK; Gupta, YK; Maulik, SK; Prabhakar, P; Reeta, KH | 1 |
Du, LB; Hai, CX; Jin, L; Li, WL; Liao, N; Pauluhn, J; Peng, J; Wang, S; Wang, X; Wang, Z; Zhang, JL; Zhao, YY | 1 |
3 other study(ies) available for oleanolic acid and D-fructopyranose
Article | Year |
---|---|
Oleanolic acid supplement attenuates liquid fructose-induced adipose tissue insulin resistance through the insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt signaling pathway in rats.
Topics: Adipose Tissue; Animals; Biomarkers; Dietary Supplements; Disease Models, Animal; Energy Metabolism; Fatty Acids, Nonesterified; Fructose; Glucose Tolerance Test; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Oleanolic Acid; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Time Factors | 2014 |
α-Amyrin attenuates high fructose diet-induced metabolic syndrome in rats.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Antioxidants; Diet, Carbohydrate Loading; Dose-Response Relationship, Drug; Fructose; Gene Expression Regulation; Hyperglycemia; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Liver; Male; Metabolic Syndrome; Oleanolic Acid; Oxidative Stress; PPAR alpha; Random Allocation; Rats, Wistar | 2017 |
Nano-oleanolic acid alleviates metabolic dysfunctions in rats with high fat and fructose diet.
Topics: Animals; Diet, High-Fat; Fructose; Insulin Resistance; Lipid Metabolism; Liver; Male; Metabolic Diseases; Nanoparticles; Oleanolic Acid; Oxidative Stress; Pancreas; Rats, Sprague-Dawley | 2018 |